Related Experiment Video
Updated: May 27, 2026
05:33
Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
Published on: August 4, 2023
Treating persistent nausea of pregnancy with hypnosis: four cases
Antonio Madrid1, Richard Giovannoli, Maureen Wolfe
1Russian River Counselors, Monte Rio, California 95462, USA. madrid@sonic.net
The American Journal of Clinical Hypnosis
|December 1, 2011
Summary
Hypnosis can rapidly resolve persistent nausea during pregnancy by addressing underlying emotional issues. This psychodynamic approach quickly uncovers and resolves the root cause of pregnancy nausea.
Area of Science:
- Psychiatry
- Psychology
- Obstetrics
Background:
- Persistent nausea and vomiting in pregnancy (NVP) significantly impacts maternal well-being.
- Psychological factors are increasingly recognized as contributors to NVP severity.
Purpose of the Study:
- To investigate the efficacy of brief, psychodynamically-oriented hypnosis in treating persistent NVP.
- To explore the role of unresolved emotional issues in the etiology of NVP.
Main Methods:
- A brief hypnosis protocol was employed for four pregnant women experiencing persistent nausea.
- Psychodynamic investigation, including David Cheek's ideomotor questioning, was used to identify the underlying cause.
- The identified cause was rapidly resolved through the hypnotic intervention.
Main Results:
- All four cases demonstrated rapid resolution of nausea following hypnotic treatment.
- The underlying psychological issues were quickly identified and addressed.
- The intervention proved effective in alleviating persistent pregnancy nausea.
Conclusions:
- Hypnosis is a potentially effective and rapid treatment for persistent nausea of pregnancy.
- Unresolved emotional or psychological issues can be a significant factor in NVP.
- Psychodynamic exploration within hypnosis can quickly identify and resolve causative factors.
More Related Videos
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:22Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...